Clinical Trial Detail

NCT ID NCT03905889
Title A Study of Abemaciclib in Combination With Sunitinib in Metastatic Renal Cell Carcinoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Milton S. Hershey Medical Center
Indications

renal cell carcinoma

Therapies

Abemaciclib + Sunitinib

Age Groups: senior adult

No variant requirements are available.